loadpatents
name:-0.029419183731079
name:-0.015762805938721
name:-0.0059468746185303
Mazdiyasni; Hormoz Patent Filings

Mazdiyasni; Hormoz

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mazdiyasni; Hormoz.The latest application filed is for "heteroaryl compounds and uses thereof".

Company Profile
9.25.30
  • Mazdiyasni; Hormoz - Marlborough MA
  • Mazdiyasni; Hormoz - Douglas MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
2,4-disubstituted pyrimidines useful as kinase inhibitors
Grant 11,351,168 - Singh , et al. June 7, 2
2022-06-07
Substituted 2,4-diaminopyrimidines as kinase inhibitors
Grant 10,828,300 - Singh , et al. November 10, 2
2020-11-10
Heteroaryl compounds and uses thereof
Grant 10,774,052 - D'Agostino , et al. September 15, 2
2020-09-15
Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases
Grant 10,618,902 - D'Agostino , et al.
2020-04-14
2,4-disubstituted pyrimidines useful as kinase inhibitors
Grant 10,596,172 - Singh , et al.
2020-03-24
Heteroaryl Compounds And Uses Thereof
App 20190375719 - D'Agostino; Laura Akullian ;   et al.
2019-12-12
Heteroaryl Compounds And Uses Thereof
App 20190218220 - D'Agostino; Laura Akullian ;   et al.
2019-07-18
Heteroaryl Compounds And Uses Thereof
App 20190192512 - Singh; Juswinder ;   et al.
2019-06-27
Heteroaryl Compounds And Uses Thereof
App 20190117650 - Singh; Juswinder ;   et al.
2019-04-25
Heteroaryl compounds and uses thereof
Grant 10,189,794 - D'Agostino , et al. Ja
2019-01-29
Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases
Grant 10,065,966 - D'Agostino , et al. September 4, 2
2018-09-04
2,4-disubstituted pyrimidines useful as kinase inhibitors
Grant 10,010,548 - Singh , et al. July 3, 2
2018-07-03
Substituted 2,4-diaminopyrimidines as kinase inhibitors
Grant 9,987,276 - Singh , et al. June 5, 2
2018-06-05
Heteroaryl Compounds And Uses Thereof
App 20180022713 - D'Agostino; Laura Akullian ;   et al.
2018-01-25
Heteroaryl Compounds And Uses Thereof
App 20170267685 - D'Agostino; Laura Akullian ;   et al.
2017-09-21
Heteroaryl compounds and uses thereof
Grant 9,695,132 - D'Agostino , et al. July 4, 2
2017-07-04
Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitors
Grant 9,663,524 - D'Agostino , et al. May 30, 2
2017-05-30
Heteroaryl Compounds And Uses Thereof
App 20170100397 - Singh; Juswinder ;   et al.
2017-04-13
Heteroaryl Compounds And Uses Thereof
App 20160303121 - Singh; Juswinder ;   et al.
2016-10-20
2,4-disubstituted pyrimidines as kinase inhibitors
Grant 9,409,921 - Singh , et al. August 9, 2
2016-08-09
Heteroaryl Compounds And Uses Thereof
App 20160221966 - D'Agostino; Laura Akullian ;   et al.
2016-08-04
Heteroaryl compounds and uses thereof
Grant 9,321,786 - D'Agostino , et al. April 26, 2
2016-04-26
Substituted 2,4-diaminopyrimidines as kinase inhibitors
Grant 9,296,737 - Singh , et al. March 29, 2
2016-03-29
Heteroaryl Compounds And Uses Thereof
App 20160046634 - D'Agostino; Laura Akullian ;   et al.
2016-02-18
Substituted 2,4-diaminopyrimidines as kinase inhibitors
Grant 9,212,181 - Singh , et al. December 15, 2
2015-12-15
Methods Of Treating A Bruton's Tyrosine Kinase Disease Or Disorder
App 20150216865 - Westlin, III; William Frederick ;   et al.
2015-08-06
Heteroaryl Compounds And Uses Thereof
App 20140296233 - D'Agostino; Laura Akullian ;   et al.
2014-10-02
Heteroaryl Compounds And Uses Thereof
App 20140213574 - Singh; Juswinder ;   et al.
2014-07-31
2,4-disubstituted pyrimidines useful as kinase inhibitors
Grant 8,710,222 - Singh , et al. April 29, 2
2014-04-29
2,4-diaminopyrimidines useful as kinase inhibitors
Grant 8,609,679 - Singh , et al. December 17, 2
2013-12-17
Heteroaryl Compounds And Uses Thereof
App 20130165462 - Singh; Juswinder ;   et al.
2013-06-27
2,4-disubstituted pyrimidines useful as kinase inhibitors
Grant 8,450,335 - Singh , et al. May 28, 2
2013-05-28
Heteroaryl Compounds And Uses Thereof
App 20130072469 - Singh; Juswinder ;   et al.
2013-03-21
Heteroaryl Compounds And Uses Thereof
App 20130065899 - Singh; Juswinder ;   et al.
2013-03-14
Heteroaryl Compounds And Uses Thereof
App 20130065879 - Singh; Juswinder ;   et al.
2013-03-14
2,4-disubstituted pyrimidines useful as kinase inhibitors
Grant 8,338,439 - Singh , et al. December 25, 2
2012-12-25
Pi3 Kinase Inhibitors And Uses Thereof
App 20110230476 - NIU; DEQIANG ;   et al.
2011-09-22
4-aminopyrrolopyrimidines as kinase inhibitors
Grant 7,863,444 - Calderwood , et al. January 4, 2
2011-01-04
Ion Channel Modulators
App 20100267697 - Galullo; Vincent P. ;   et al.
2010-10-21
Heteroaryl Compounds And Uses Thereof
App 20100249092 - Singh; Juswinder ;   et al.
2010-09-30
Beta-carbolines useful for treating inflammatory disease
Grant 7,727,985 - Hepperle , et al. June 1, 2
2010-06-01
Beta-carbolines Useful For Treating Inflammatory Disease
App 20100093713 - Hepperle; Michael E. ;   et al.
2010-04-15
Heteroaryl Compounds and Uses Thereof
App 20100029610 - Singh; Juswinder ;   et al.
2010-02-04
Ion channel modulators
Grant 7,368,467 - Zelle , et al. May 6, 2
2008-05-06
Ion Channel Modulators
App 20080090891 - Zelle; Robert ;   et al.
2008-04-17
Substituted .beta.-carbolines
Grant 7,348,336 - Ritzeler , et al. March 25, 2
2008-03-25
Ion Channel Modulators
App 20070281937 - Zelle; Robert ;   et al.
2007-12-06
Substituted beta carbolines
App 20060166978 - Ritzeler; Olaf ;   et al.
2006-07-27
Substituted beta-carbolines
Grant 7,026,331 - Ritzeler , et al. April 11, 2
2006-04-11
Ion channel modulators
App 20050203159 - Zelle, Robert ;   et al.
2005-09-15
Beta-carbolines useful for treating inflammatory disease
App 20040235839 - Hepperle, Michael E. ;   et al.
2004-11-25
Substituted beta carbolines
App 20040110759 - Ritzeler, Olaf ;   et al.
2004-06-10
4-aminopyrrolopyrimidines As Kinase Inhibitors
App 20030187001 - CALDERWOOD, DAVID ;   et al.
2003-10-02
Substituted beta carbolines
App 20020099068 - Ritzeler, Olaf ;   et al.
2002-07-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed